Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell
Stephan
S
Abteilung für Infektions- und Tropenmedizin, Klinikum Innenstadt der Ludwigs-Maximilians-Universität München, Munich, Germany. stephan.proell@epost.de
D000293:Adolescent; D000328:Adult; D004334:Drug Administration Schedule; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control; D022362:Hepatitis A Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D014435:Typhoid Fever / Q000276:immunology / Q000517:prevention & control; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines; D014436:Typhoid-Paratyphoid Vaccines; D017778:Vaccines, Combined